Algorae Pharmaceuticals Limited
LVCLF
$0.0063
$0.000916.67%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 2.74% | -3.01% | -0.19% | 55.18% | 0.48% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2.50% | -114.10% | 0.18% | -21.43% | -0.48% |
| Change in Net Operating Assets | -- | -- | -0.28% | -- | -- |
| Cash from Operations | 2.73% | -38.38% | -0.24% | 48.52% | 0.45% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -2.69% | -70.95% | 0.17% | 172.28% | 0.47% |
| Cash from Investing | -2.69% | -70.95% | 0.17% | 172.28% | 0.47% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | 0.00% | -90.09% | 0.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 0.00% | -- | -- |
| Cash from Financing | -- | -- | 0.00% | -99.53% | -0.47% |
| Foreign Exchange rate Adjustments | 0.00% | 40.00% | 0.00% | -150.00% | 0.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 2.74% | -374.06% | 0.33% | 112.79% | 0.48% |